Atay, D. Et Al. 2014. ORAL VALGANCICLOVIR IS EFFECTIVE AS PRE-EMPTIVE THERAPY FOR CYTOMEGALOVIRUS INFECTION IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS. 40th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation , (Milan, Italy).

Atay, D., Erbey, F., Akcay, A., Dag, A., & Ozturk, G., (2014). ORAL VALGANCICLOVIR IS EFFECTIVE AS PRE-EMPTIVE THERAPY FOR CYTOMEGALOVIRUS INFECTION IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS . 40th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Milan, Italy

Atay, DİDEM Et Al. "ORAL VALGANCICLOVIR IS EFFECTIVE AS PRE-EMPTIVE THERAPY FOR CYTOMEGALOVIRUS INFECTION IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS," 40th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Milan, Italy, 2014

Atay, DİDEM Et Al. "ORAL VALGANCICLOVIR IS EFFECTIVE AS PRE-EMPTIVE THERAPY FOR CYTOMEGALOVIRUS INFECTION IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS." 40th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation , Milan, Italy, 2014

Atay, D. Et Al. (2014) . "ORAL VALGANCICLOVIR IS EFFECTIVE AS PRE-EMPTIVE THERAPY FOR CYTOMEGALOVIRUS INFECTION IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS." 40th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation , Milan, Italy.

@conferencepaper{conferencepaper, author={DİDEM ATAY Et Al. }, title={ORAL VALGANCICLOVIR IS EFFECTIVE AS PRE-EMPTIVE THERAPY FOR CYTOMEGALOVIRUS INFECTION IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS}, congress name={40th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation}, city={Milan}, country={Italy}, year={2014}}